ASH 2025 | Lymphoma and Myeloproliferative Neoplasms Highlights
We are pleased to invite you to attend this interactive, scientific-exchange meeting, where experts will present lymphoma and myeloproliferative neoplasms data highlights from the ASH 2025 congress.
Following each expert presentation there will be an open discussion; you are strongly encouraged to take this opportunity to put your thoughts and questions to the speakers and engage in this interactive discussion and debate.
This non-promotional, scientific exchange meeting is organised and funded by the medical department of Takeda UK Ltd and is intended for healthcare professionals from the UK and Ireland with a clinical speciality in haemato-oncology only.
Wednesday 14 January, 2026
Agenda Details
The meeting can be attended in person or via live webcast. For those attending in person, registration and a hot buffet will be available from 17:15.
Welcome and introduction
The Freeman Hospital, Newcastle upon Tyne
Myeloproliferative neoplasms
The Freeman Hospital, Newcastle upon Tyne
Interactive discussion and debate
Low-grade lymphoma and CLL
The Freeman Hospital, Newcastle upon Tyne
Interactive discussion and debate
Coffee break
High-grade lymphoma
The Freeman Hospital, Newcastle upon Tyne
Interactive discussion and debate
Hodgkin lymphoma and T-cell lymphoma
Churchill Hospital, Oxford
Interactive discussion and debate
Panel discussion and debate
Close
The Freeman Hospital, Newcastle upon Tyne
Dr Wendy Osborne (Chair)
Consultant Haematologist,
The Freeman Hospital, Newcastle upon Tyne
Dr Andrew McGregor
Consultant Haematologist,
The Freeman Hospital, Newcastle upon Tyne
Dr Helen Marr
Consultant Haematologist,
The Freeman Hospital, Newcastle upon Tyne
Dr Tobias Menne
Consultant Haematologist,
The Freeman Hospital, Newcastle upon Tyne
Professor Graham Collins
Consultant Haematologist,
Churchill Hospital, Oxford
